These observations are in accordance with the role of LCN-2 as a pro-tumour factor in a variety of other urogenital neoplasms, including prostate,30 endometrial,31 ovarian32 and breast cancer.11 However, the underlying mechanisms of its pro-tumour activity are still poorly understood. This evidence concerns the gene LCN2 and breast carcinoma.